Faculty & Staff Details
|Name:||Krystal Haase, Pharm.D., FCCP, BCPS|
|Position:||Associate Professor, Adult Medicine Division, Amarillo|
|Bio||Dr. Haase is an Associate Professor at Texas Tech University Health Sciences Center School of Pharmacy, Amarillo and is a Clinical Pharmacist Specialist in Critical Care and Adult Medicine at Northwest Texas Hospital. She has served as Program Director for the 24-month Pharmacotherapy Specialty Residency training program in Amarillo since 2000.
She received her Pharm.D. from the University of Texas at Austin and the UT Health Sciences Center in San Antonio and subsequently completed a two-year ASHP/ACCP Accredited Residency in Pharmacotherapy at the Medical University of South Carolina in Charleston, South Carolina. Dr. Haase’s research interests parallel her practice focus in critical care and infectious diseases, in particular evaluating outcomes from sepsis in different patient populations. She is also actively involved in scholarship related to experiential training of both students and residents.
• Doctor of Pharmacy, The University of Texas at Austin and The University of Texas Health Science Center at San Antonio, May 1997
• 24-Month ASHP Accredited Pharmacotherapy Specialty Residency, Medical University of South Carolina, Charleston, South Carolina 1997 – 1999
• The ACCP Leadership Experience, LeaderPointTM, LLC Comprehensive Management Development Program, Mission, Kansas, February 2003
• Texas Pharmacy License, No. 38543, 1999 - present
• South Carolina Pharmacy License, No. 009411, 1997 – 2000
• Licensed Pharmacist Preceptor, 1999 – present
• Board Certified Pharmacotherapy Specialist, No. 200156, 2000 – present
• P2 Teaching Team of the Year Award, Infectious Diseases Pharmacotherapy Team, Texas Tech UHSC School of Pharmacy, May 2007
• P3 Clerkship Preceptor of the Year, Texas Tech UHSC School of Pharmacy, 2002 and 2006
• Presidential Safety Award, Texas Tech University Health Sciences Center, 2002
Dr. Haase’s research expertise is in the area of critical care, particularly focusing on sepsis treatment strategies and outcomes from sepsis across different patient populations. Dr. Haase’s previous work was in infectious diseases including pharmacodynamics and characterization of pathogens based upon potential for resistance development. Her collaborative projects have been presented at national conferences. In addition to practice-based research, Dr. Haase has a secondary interest in research based upon experiential education of both students and residents.
Dr. Haase practices at Northwest Texas Hospital as a member of the Texas Tech Critical Care and Internal Medicine rounding teams. Dr. Haase has previously practiced in the Infectious Disease Clinic at the Amarillo VA Medical Center.
Dr. Haase is involved in several professional organizations. She has served as Chair of the Adult Medicine Practice and Research Network and has served as member or chair for several committees for the American College of Clinical Pharmacists (ACCP). She most recently chaired the Educational Affairs Subcommittee that developed both a White Paper and Position Statement on Quality Experiential Education and is currently chair of a task force that is developing guidelines for assessment of direct patient care experiences. Dr. Haase has supported residency training at the local, state, and national level. She was Vice-Chair for Residency Programs for Texas Tech (2001-2005), was a member of the Southwestern Residency Leadership Conference Advisory Council, and was recently invited to serve as a content expert for the revision of the ASHP Pharmacotherapy Residency Training Standards.
Haase KK, Smythe MA, Orlando PL, Resman-Targoff BH, Smith LS. ACCP Position Statement: Quality Experiential Education. American College of Clinical Pharmacy. Pharmacotherapy. In press. Published electronically at http://www.accp.com.
Haase KK, Smythe MA, Orlando PL, Resman-Targoff BH, Smith LS. ACCP White Paper: Quality Experiential Education. American College of Clinical Pharmacy. Pharmacotherapy. In press. Published electronically at http://www.accp.com.
Gallegos PJ, MacLaughlin EJ, Haase KK. Emerging use of Brain Natriuretic Peptide for Monitoring and Titration of Drug Therapy in Patients with Heart Failure. Pharmacotherapy. In press.
Nappi JM, Haase KK, Kessels A, Fink, J. What is a pharmacotherapy residency? Benefits of a 24 month program. Pharmacotherapy. Accepted for publication Dec 2007.
McCall KL, Raehl CL, Nelson S, Haase KK. Evaluation of blood pressure and heart rate reading accuracy as measured by students in the second professional year of a doctor of pharmacy program. Am J Pharm Educ 2007;71:Article 01.
Haase KK, McCracken KA, Akins RL. Catheter related bloodstream infections in the intensive care unit population. J Pharm Pract 2005;18;1:42-52.
Akins RL, Haase KK. Gram-positive resistance: pathogens, implications, and treatment options. Pharmacotherapy 2005;25:1001-10.
Akins RL, Haase KK. Gram-positive resistance: pathogens, implications and treatment options. Society of Infectious Diseases Pharmacotherapy Newsletter 2004;14:2-7.
Roach AE, Tsikouris JP, Haase KK. Rosuvastatin: a new HMG-CoA reductase inhibitor for hypercholoesterolemia. Formulary 2002;37:179-185.
Cunningham AJ, Haase KK. Valdecoxib: A new COX-2 inhibitor. AJPM 2002;12:86-94.
Haase KK, Rojas-Fernandez CH, Lane L, Frank DA. Potential interaction between celecoxib and warfarin. Annals of Pharmacotherapy 2000;34:666-7.
Haase KK, Lapointe M, Haines SJ. Aseptic meningitis after intraventricular administration of gentamicin. Pharmacotherapy 2001;21:103-7.
King SE, Haase KK, Canales AE. The impact of hospitalization on inappropriate medication use in elderly patients. Pharmacotherapy 2006;26:e113. Presented at the 2006 Annual Meeting of the American College of Clinical Pharmacy (Abstract 372), October 28, 2006.
McCracken KA, Haase KK, Akins RL. Characterization of community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA) infections and outcomes. Pharmacotherapy 2005;25:1460 (A-178). Presented at the 2005 Annual Meeting of the American College of Clinical Pharmacy, October 26, 2005.
Haase KK, Akins RL, Bouma CL, Morris AJ. Relationship of inoculum and beta-lactam exposure on mutation selection in P. aeruginosa. Pharmacotherapy 2004;24:1442 (A-141E).
Akins RL, Haase KK, Bouma CL, Morris AJ. Analysis of daptomycin population susceptibility profiles and killing activity against two clinical strains of vancomycin-resistant Staphylococcus aureus in an in vitro simulated endocardial vegetation infection model (SEVM). Pharmacotherapy 2004;24:1443 (A-150E).
Akins RL, Haase KK, Bouma CL, Morris AJ. Analysis of daptomycin population susceptibility profiles and killing activity against two clinical strains of vancomycin-resistant Staphylococcus aureus in an in vitro simulated endocardial vegetation infection model (SEVM). In Programs and Abstracts of the 104th General Meeting of the American Society for Microbiology General Meeting, New Orleans, Louisiana, May 23-27, 2004. (A-048).
Cox CD, Stanford BL, Brouse S, Seifert CF, Haase KK, Akins RL, Bowie VL, Tsikouris JP, Busti AJ, Shah S, Hall R. Validation of an experiential teaching peer assessment tool. Pharmacotherapy 2004;24:1430 (A-62).
Dunlap RB, Haase KK, Akins RL. Evaluation of glycemic control with continuous infusion and sliding scale insulin in medical intensive care unit patients. Presented at the Texas Society of Health System Pharmacists 56th Annual Seminar, Houston, TX, April 2004.
Maki ED, Haase KK. Evaluation of venous thromboembolism prophylaxis in stroke patients. Presented at the Texas Society of Health System Pharmacists 56th Annual Seminar, Houston, TX, April 2004. Encore presentation at the 2004 TTUHSC Research Days, July 29-30, 2004.
Akins RL, Haase KK, Bouma CL, Morris AJ. Relationship of Inoculum and Beta-Lactam (BL) Exposure on Mutation Selection in P. aeruginosa. Abstract: D-236. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, September, 2003.
Cox CD, Stanford BL, Brouse S, Seifert CF, Haase KK, Akins RL, Bowie VL, Tsikouris JP, Busti AJ, Shah S, Hall R. Development of an Experiential Teaching Assessment Tool. Abstract 57. American College of Clinical Pharmacy 2003 Annual Meeting, Atlanta, Georgia, November 2003.
Haase KK. Incorporating Clinician-Educator Training into a School of Pharmacy-Based Residency Program to Cultivate Future Academicians. American Association of Colleges of Pharmacy 2002 Annual Meeting. 2002;103(Jul):33.
Haase KK, Akins RL. Comparison of various fluoroquinolones (FQs) and four other antibiotics by mutant prevention concentration (MPC) against multi-drug resistant gram-negatives utilizing kill curves based on MPC-derived doses. Abstract 2338. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 2002.
Akins RL, Haase KK. Evaluation of mutant prevention concentration (MPC) of multiple antibiotics in Klebsiella pneumoniae (KP) and Echerichia coli (EC). Abstract 2354. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 2002.
Haase KK, Cunningham AJ, Roach AE. Development of clinician-educators within a two-year pharmacotherapy residency program. [Abstract of meeting presentation. Journal article] ASHP Midyear Clinical Meeting, 36(Dec):p P-221D.2001.
Roach AE, Anderson AC, Berk SL, Haase KK, Akins RL, MacLaughlin EJ, Nixon-Lewis B, Raehl CL. A randomized trial of once daily levofloxacin versus once daily ceftriaxone for treatment of nursing home-acquired pneumonia and prospective pharmacokinetic study of levofloxacin. ASHP Midyear Clinical Meeting, New Orleans, LA, December 2001.
Cunningham, AJ, Anderson AC, Berk SL, Chittivelu S, Haase KK, Akins RL. A prospective clinical pharmacodynamic study of Tequin®; its clinical efficacy and tolerability in geriatric patients with community acquired pneumonia. ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2000.
Nappi JM, Page RL, Keyes K. Integrated 24-month pharmacy practice/pharmacotherapy residency program. [Abstract of meeting presentation. Journal article] ASHP Midyear Clinical Meeting. 32(Dec):p RES-17. 1997.